MoneyWorks4Me

Strides Pharma Scien - Quaterly Results

14 Nov 2022 Evaluate
The sales declined to Rs. 4812.35 millions for the September 2022 quarter as compared to Rs. 5749.97 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2022 is Rs. -39.97 millions as compared to Net Profit of Rs. 185.18 millions of corresponding quarter ended September 2021The company reported a degrowth in operating Profit to 149.40 millions from 693.74 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 4812.35 5749.97 -16.31 9044.25 10837.87 -16.55 19790.03 18575.66 6.54
Other Income 204.71 224.10 -8.65 279.36 340.96 -18.07 1234.85 889.96 38.75
PBIDT 149.40 693.74 -78.46 -386.27 863.10 -144.75 2001.15 2763.16 -27.58
Interest 346.60 180.03 92.52 606.77 360.94 68.11 742.41 653.39 13.62
PBDT -197.20 513.71 -138.39 -993.04 502.16 -297.75 1258.74 2109.77 -40.34
Depreciation 243.51 270.89 -10.11 486.47 537.25 -9.45 1043.66 993.42 5.06
PBT -440.71 242.82 -281.50 -1479.51 -35.09 4116.33 215.08 1116.35 -80.73
TAX -400.74 57.64 -795.25 -777.00 -7.96 9661.31 -1586.80 333.95 -575.16
Deferred Tax -205.93 57.64 -457.27 -582.19 -7.96 7213.94 -2.09 123.77 -101.69
PAT -39.97 185.18 -121.58 -702.51 -27.13 2489.42 1801.88 782.40 130.30
Equity 902.90 897.77 0.57 902.90 897.77 0.57 897.90 896.80 0.12
PBIDTM(%) 3.10 12.07 -74.27 -4.27 7.96 -153.63 10.11 14.88 -32.02
Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..